These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 25850301)
1. [Modification of [PSI+] prion properties by the combination of amino acid changes within Sup35 protein N-domain]. Bondarev SA; Shirokolobova ED; Trubitsyna NP; Zhuravleva GA Mol Biol (Mosk); 2014; 48(2):314-21. PubMed ID: 25850301 [TBL] [Abstract][Full Text] [Related]
2. Effect of charged residues in the N-domain of Sup35 protein on prion [PSI+] stability and propagation. Bondarev SA; Shchepachev VV; Kajava AV; Zhouravleva GA J Biol Chem; 2013 Oct; 288(40):28503-13. PubMed ID: 23965990 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of inhibition of Psi+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein. Kochneva-Pervukhova NV; Paushkin SV; Kushnirov VV; Cox BS; Tuite MF; Ter-Avanesyan MD EMBO J; 1998 Oct; 17(19):5805-10. PubMed ID: 9755180 [TBL] [Abstract][Full Text] [Related]
4. The [PSI+] prion exists as a dynamic cloud of variants. Bateman DA; Wickner RB PLoS Genet; 2013; 9(1):e1003257. PubMed ID: 23382698 [TBL] [Abstract][Full Text] [Related]
6. Nonsense Mutations in the Yeast Trubitsina NP; Zemlyanko OM; Bondarev SA; Zhouravleva GA Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121268 [TBL] [Abstract][Full Text] [Related]
7. A mutation within the C-terminal domain of Sup35p that affects [PSI+] prion propagation. Kabani M; Cosnier B; Bousset L; Rousset JP; Melki R; Fabret C Mol Microbiol; 2011 Aug; 81(3):640-58. PubMed ID: 21631606 [TBL] [Abstract][Full Text] [Related]
8. The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast. Derkatch IL; Bradley ME; Zhou P; Liebman SW Curr Genet; 1999 Mar; 35(2):59-67. PubMed ID: 10079323 [TBL] [Abstract][Full Text] [Related]
9. [Identification of new genes that affect [PSI^(+)] prion toxicity in Saccharomyces cerevisiae yeast]. Matveenko AG; Belousov MV; Bondarev SA; Moskalenko SE; Zhouravleva GA Mol Biol (Mosk); 2016; 50(5):803-813. PubMed ID: 27830682 [TBL] [Abstract][Full Text] [Related]
10. [Rnq1 protein protects [PSI^(+)] prion from effect of the PNM mutation]. Bondarev SA; Likholetova DV; Belousov MV; Zhouravleva GA Mol Biol (Mosk); 2017; 51(2):367-371. PubMed ID: 28537243 [TBL] [Abstract][Full Text] [Related]
11. Prion properties of the Sup35 protein of yeast Pichia methanolica. Kushnirov VV; Kochneva-Pervukhova NV; Chechenova MB; Frolova NS; Ter-Avanesyan MD EMBO J; 2000 Feb; 19(3):324-31. PubMed ID: 10654931 [TBL] [Abstract][Full Text] [Related]
12. [Mechanism and application of molecular self-assembly in Sup35 prion domain of Saccharomyces cerevisiae]. Yin W; He J; Yu Z; Wang J Sheng Wu Gong Cheng Xue Bao; 2011 Oct; 27(10):1401-7. PubMed ID: 22260056 [TBL] [Abstract][Full Text] [Related]
13. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Derkatch IL; Uptain SM; Outeiro TF; Krishnan R; Lindquist SL; Liebman SW Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12934-9. PubMed ID: 15326312 [TBL] [Abstract][Full Text] [Related]
14. Increased [PSI+] appearance by fusion of Rnq1 with the prion domain of Sup35 in Saccharomyces cerevisiae. Choe YJ; Ryu Y; Kim HJ; Seok YJ Eukaryot Cell; 2009 Jul; 8(7):968-76. PubMed ID: 19411620 [TBL] [Abstract][Full Text] [Related]
15. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. Paushkin SV; Kushnirov VV; Smirnov VN; Ter-Avanesyan MD EMBO J; 1996 Jun; 15(12):3127-34. PubMed ID: 8670813 [TBL] [Abstract][Full Text] [Related]
16. The interaction of Hsp104 with yeast prion Sup35 as analyzed by fluorescence cross-correlation spectroscopy. Ohta S; Kawai-Noma S; Kitamura A; Pack CG; Kinjo M; Taguchi H Biochem Biophys Res Commun; 2013 Dec; 442(1-2):28-32. PubMed ID: 24216111 [TBL] [Abstract][Full Text] [Related]
17. Interaction of human laminin receptor with Sup35, the [PSI⁺] prion-forming protein from S. cerevisiae: a yeast model for studies of LamR interactions with amyloidogenic proteins. Pampeno C; Derkatch IL; Meruelo D PLoS One; 2014; 9(1):e86013. PubMed ID: 24416454 [TBL] [Abstract][Full Text] [Related]
18. Conformation preserved in a weak-to-strong or strong-to-weak [PSI+] conversion during transmission to Sup35 prion variants. Crist CG; Kurahashi H; Nakayashiki T; Nakamura Y Biochimie; 2006 May; 88(5):485-96. PubMed ID: 16364534 [TBL] [Abstract][Full Text] [Related]
19. Growth phase-dependent changes in the size and infectivity of SDS-resistant Sup35p assemblies associated with the [PSI Wang K; Melki R; Kabani M Mol Microbiol; 2019 Sep; 112(3):932-943. PubMed ID: 31206803 [TBL] [Abstract][Full Text] [Related]
20. The role of the N-terminal oligopeptide repeats of the yeast Sup35 prion protein in propagation and transmission of prion variants. Shkundina IS; Kushnirov VV; Tuite MF; Ter-Avanesyan MD Genetics; 2006 Feb; 172(2):827-35. PubMed ID: 16272413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]